Congress Park Capital LLC

Position in LLY — ELI LILLY & Co

CIK 1730945 SARATOGA SPRINGS, NY

Position in LLY

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$4,326,344

+$1,006,895 QoQ

Shares Held

3,607

-0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.54%

of 13F equity value

Holder Rank

#1,829

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Congress Park Capital LLC holds $10,199,729 across 8 Drug Manufacturers - General names. LLY ranks #1 (42.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	3,607	$4,326,344
2	AMGN	Amgen Inc	5,130	$1,857,675
3	JNJ	Johnson & Johnson	6,838	$1,736,646
4	ABBV	AbbVie Inc.	3,637	$915,214
5	MRK	Merck & Co., Inc.	5,060	$650,210
6	GILD	Gilead Sciences, Inc.	2,225	$281,106
7	PFE	Pfizer Inc	9,551	$229,988
8	NVO	Novo Nordisk A S	4,225	$202,546

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,326,344	3,607	-0.1%	Shares	Sole	2026-07-14
2026-03-31	$3,319,449	3,609	-1.3%	Shares	Sole	2026-04-14
2025-12-31	$3,931,179	3,658	-1.5%	Shares	Sole	2026-01-14
2025-09-30	$2,833,019	3,713	+11.6%	Shares	Sole	2025-10-08
2025-06-30	$2,593,496	3,327	+4.7%	Shares	Sole	2025-07-11
2025-03-31	$2,623,916	3,177	-0.2%	Shares	Sole	2025-04-22
2024-12-31	$2,458,048	3,184	-0.7%	Shares	Sole	2025-01-15
2024-09-30	$2,842,095	3,208	-0.7%	Shares	Sole	2024-10-09
2024-06-30	$2,924,377	3,230	-0.7%	Shares	Sole	2024-07-12
2024-03-31	$2,529,925	3,252	-5.3%	Shares	Sole	2024-04-16
2023-12-31	$2,001,164	3,433	-6.3%	Shares	Sole	2024-01-19
2023-09-30	$1,966,970	3,662	+19.8%	Shares	Sole	2023-10-13
2023-06-30	$1,433,202	3,056	+57.4%	Shares	Sole	2023-07-14
2023-03-31	$666,578	1,941	0.0%	Shares	Sole	2023-04-20
2022-12-31	$710,095	1,941	—	Shares	Sole	2023-01-30
No filing history on record for this holder in this stock.